Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LINGO1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP5-860F19.8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | CD151 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | AGAP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RALGAPA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KBTBD8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | CA6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | KLHL12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |